A cost-effectiveness analysis of changes in therapeutic strategies in the treatment of HIV since 1996;Une analyse coût-efficacité du changement des schemas thérapeutiques dans le VIH depuis 1996

Therapie

Volumn 57, Issue 1, 2002, Pages 27-33

  Le Pen, Claude ^a   Rozenbaum, W ^a   Downs, A ^a   Lilliu, H ^a   Maurel, F ^a   Foucher, F ^a  

^a CLP Sante   (France)

Author keywords

Cost effectiveness; HAART; HIV AIDS

Indexed keywords

ANTIRETROVIRUS AGENT; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ARTICLE; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST CONTROL; COST OF ILLNESS; DRUG COST; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOSPITALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; COST-BENEFIT ANALYSIS; FRANCE; HIV INFECTIONS; HUMANS; T-LYMPHOCYTES;

EID: 0036262426     PISSN: 00405957     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Anti-human immunodeficiency virus drug combination strategies
2. New approaches to using antiretroviral therapy for the management of HIV infection
3. Advances in antiretroviral therapy and viral load monitoring
4. Surveillance du sida en France. Situation après deux ans d'interruption
5. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection
6. Impact of protease inhibitors on AIDS-defining events and hospitalisations in 10 French AIDS reference centres
7. Decreased medical expenditures for care of HIV-seropositive patients. The impact of highly active antiretroviral therapy at a US Veterans Affairs Medical Center
8. Effect of HAART on health status and hospital costs of severe HIV-infected patients: A modeling approach
9. Cost effectiveness of combination HIV. Therapy 3 years later
10. Recommandations de bonnes pratiques des méthodes d'évaluation économique des stratégies thérapeutiques
11. T-tests for paired data
12. Expenditures for the care of HIV-infected patients in the era of highly active antiretroviral therapy